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Heme Oxygenase-1–Related Carbon Monoxide and
Flavonoids in Ischemic/Reperfused Rat Retina
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Joel de Leiris,3 Norbert Nagy,2 Edit Varga,2 and Arpad Tosaki2
PURPOSE. There is increasing evidence to show cytoprotective
effects of various flavonoid-rich extracts and the tissue-protec-
tive capacity of flavonoid-rich extract of sour cherry is due to
flavonoid components of seeds. Sour cherry seed flavonoids
were evaluated for their contribution to postischemic recovery
related to endogenous carbon monoxide (CO) production in
rat retinas subjected to ischemia/reperfusion.
METHODS. Rats were orally treated with selected doses of fla-
vonoid-rich extract of sour cherry seeds for 2 weeks. Animals
were anesthetized, and a suture was placed behind the globe
including the central retinal artery. Next, retinas were sub-
jected to 90 minutes of ischemia followed by 24 hours of
reperfusion. After this procedure, heme oxygenase-1 (HO-1)–
related protein expression and enzyme activity, HO-1–related
endogenous CO production, and ionic imbalance including
tissue Na, K, and Ca2 in untreated and treated ischemic/
reperfused retinas were measured.
RESULTS. Retinal ischemia/reperfusion resulted in a significant
reduction (to 10%) in HO-1 protein expression, enzyme activ-
ity, and HO-1–related endogenous CO production in the retina.
These changes were accompanied by increases in retinal Na
and Ca2 gains and loss of K. In rats treated with 10 and 30
mg/kg of sour cherry flavonoid–rich extract, after 24 hours of
reperfusion, tissue Na and Ca2 accumulation and K loss
were prevented in comparison with the drug-free control.
CONCLUSIONS. Sour cherry seed flavonoid–rich extract showed a
protective effect against reperfusion-induced injury through its
ability to reduce the changes in concentrations of retinal ions
through HO-1–related endogenous CO production in the isch-
emic/reperfused retina. (Invest Ophthalmol Vis Sci. 2004;45:
3727–3732) DOI:10.1167/iovs.03-1324
The discovery of endothelium-derived relaxing factor(EDRF) in the 1970s and its identification as nitric ox-
ide (NO) in the late 1980s revealed a novel role for endog-
enous gaseous compounds, including NO as mediators
of diverse and critical effects on an enormous range of
cellular and organ functions. It has also been known for
some time that in addition to NO, another gaseous mole-
cule, carbon monoxide (CO) is generated under physiolog-
ical conditions. In viable cells and organs the heme oxygen-
ase (HO) enzyme system is primarily responsible for CO
production.1,2
Adaptation of cells and tissues to ischemia or hypoxia is
of fundamental importance in developmental, physiological,
and pathophysiological processes. Cells, tissues, and organs
of humans and other mammals respond to low oxygen
tension in part by finely tuned expression of a group of
physiologically relevant genes, proteins, and enzymes. The
microsomal heme oxygenase (HO), originally identified by
Tenhunen et al.,3 catalyzes the oxidative degradation of
heme to biliverdin, which is subsequently converted to
bilirubin by biliverdin reductase.3,4 Mammalian heme oxy-
genase, which catabolizes cellular heme to biliverdin, car-
bon monoxide (CO), and free iron, is represented by three
isoforms, HO-1, -2, and -3 encoded by separate genes. HO-3,
which in its primary structure resembles HO-2, is marginally
active.5 Evidence has recently accumulated suggesting that
CO generated by HO may be a physiological signaling mol-
ecule.6,7 HO may also function as an antioxidant defense
mechanism, a possibility suggested on the basis of its
marked upregulation in stressed cells,8,9 including those in
tissue subjected to ischemia/reperfusion. One important in-
terpretation of the aforementioned findings is that HO-1 may
serve as a key endogenous factor in the adaptation and/or
defense against oxidative and cellular stress. Thus, it is
reasonable to assume that a relationship may exist between
the HO system and endogenous CO production. Keyse and
Tyrrell8 showed that expression of HO-1 is also substantially
induced by a variety of molecules causing oxidative stress.
Consequently, many investigators have recently focused
their attention on the role, function, and regulation of HO-
1–related endogenous CO formation in various in vivo and in
vitro models. Although the function of HO-1 has recently
been extensively studied at the cellular level, comparatively
little attention, to our knowledge, has been given to HO-1–
related endogenous CO production in the ischemic/reper-
fused retina. In a previous study, Bak et al.10 observed a
reduction in HO-1 mRNA expression and enzyme activity in
ischemic/reperfused myocardium. This finding led us to
speculate that the reduction in HO-1 mRNA expression may
change the endogenous CO production in ischemic/reper-
fused retina. If this is the case, HO-1–regulated endogenous
CO production and its vasodilator or cytoprotective activity
may play a role in the control of reperfusion-induced retinal
damage. The overall objectives of the present investigation
were to study: (1) formation of endogenous CO levels using
gas chromatography, (2) the role of HO-1 protein expression
and endogenous CO production on reperfusion, and (3) the
effect of flavonoid-rich extract obtained from the seed of
sour cherry on HO-1 protein expression, enzyme activity,
endogenous tissue CO formation, and tissue Na, K, and
Ca2 contents, in ischemic/reperfused retina.
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METHODS
Ischemia and Reperfusion
Rats were anesthetized with pentobarbital (60 mg/kg, intraperitone-
ally), and the central retinal artery was occluded as described in detail
elsewhere.11 In brief, the pupils were maximally dilated with atropine
sulfate (1%) administered drop-wise, and lids were retracted by su-
tures. At the onset of each experiment peritomy was performed, and a
traction-type occluder consisting of a silk suture thread through a
polyethylene guide cannula was used for retinal artery occlusion. The
suture was positioned behind the globe loosely around the optic nerve,
central retinal artery, ciliary arteries, and the retrobulbar connective
tissue using an operating microscope. Regional ischemia could be
induced as desired by pulling the suture while pressing the tube
against the surface of the optic nerve. Ischemia may then be main-
tained for any desired length of time by clamping the tube and the
suture. After the designated period of ischemia, release of the occluder
results in reperfusion of the eye. The successful induction of ischemia
and the adequacy of reperfusion were confirmed visually by an oph-
thalmoscope. All animals were handled and received humane care in
compliance with the ARVO Statement for the Use of Animals in Oph-
thalmic and Vision Research and the NIH Guidelines. The institutional
review board of the University of Debrecen, Hungary, approved the
research.
Measurement of Tissue CO Content
Retinal CO content was measured using a gas chromatograph, as
previously described.12 After 90 minutes of ischemia followed by 24
hours of reperfusion, retinas were removed from rat eyes and homog-
enized in 4 volumes of 0.1 M phosphate buffer (pH 7.4) using a
homogenizer (model X520; Ingenieurburo CAT; M. Zipperer GmbH,
Staufen, Germany) at 4°C to 7°C. Homogenates were centrifuged at
4°C for 15 minutes at 12,800g, and the supernatant fractions were used
for the determination of tissue CO. Reaction mixtures contain 150 L
of supernatant, 60 L of NADPH (4.5 mM) and 50 L of 3.5/0.35 mM
methemalbumin (a mixture [1:10] of hemin [Sigma-Aldrich, St. Louis,
MO] and bovine serum albumin [Sigma-Aldrich], and for blank samples
60 L phosphate buffer was added instead of NADPH. Samples were
preincubated at 37°C for 5 minutes, and the headspace was purged and
the incubation continued for 1 hour in the dark at 37°C. The reaction
was stopped by placing the samples on ice and the headspace gas was
analyzed. One thousand microliters of the headspace gas from each vial
was injected into the gas chromatograph with a gas-tight syringe
(volume, 2.5 mL; Hamilton Co., Reno, NV) in argon gas flow with a
speed of 20 mL/min. Analysis took place during the next 90 seconds on
a 240-cm stainless-steel column with a 0.3-cm inner diameter. Values
were expressed in microvolts, then peak areas were integrated and
expressed in arbitrary units. The column was packed with mesh
(Chromosorb 80/100, 10% Carbowax 20 M; both from Supelco, Buda-
pest, Hungary; 3.5% KOH) and maintained at 120°C. The temperature
of the column and the injector was controlled and kept at 150°C.
Western Blot Analysis
Detached retinas were homogenized in Tris-HCl (13.2 mM/L), glycerol
(5.5%), SDS (0.44%), and -mercaptoethanol. The same amount of
soluble protein (50 g) was fractionated by Tris-glycine-SDS-polyacryl-
amide gel (12%) electrophoresis, and Western blot was performed as
described by Pellacani et al.13 with the use of an antibody to recom-
binant rat HO-1 protein (1:1000; StressGen, Victoria, British Columbia,
Canada). The relative HO-1 protein expression was analyzed by densi-
tometry.
HO Activity Assay
At the end of reperfusion, the retinal tissue was homogenized in 10 mL
of 200 mM phosphate buffer, and the homogenate was centrifuged at
19,000g 4°C for 10 minutes. The supernatant was removed and recen-
trifuged at 100,000g 4°C for 60 minutes, and the precipitated fraction
was suspended in 2 mL of 100 mM potassium phosphate buffer.
Biliverdin reductase was crudely purified by the technique of Ten-
hunen et al.4 HO activity was assayed as described by Yoshida et al.14
Reaction mixtures consisted of 100 M potassium phosphate (pH 7.4),
15 nM hemin, 300 M bovine serum albumin, 1 mg biliverdin reduc-
tase, and 1 to 2 mg microsomal fraction of retinal tissue (final volume
of 2 mL). The reaction was allowed to proceed for 1 hour at 37°C in the
dark in a shaking water bath and was stopped by placing the test tube
on ice. Incubation mixtures were then scanned using a scanning
spectrophotometer, and the amount of bilirubin was calculated as the
difference between absorbance at 464 and 530 nm.15 Protein content
was determined with Folin-phenol reagent according to Lowry et al.16
in the microsomal fraction.
Measurement of Retinal Na, K,
and Ca2 Contents
At the end of the reperfusion period (after 24 hours), rats were
reanesthetized with pentobarbital (60 mg/kg intraperitoneally), the
chest was opened, and a perfusion cannula was inserted through the
heart into the aorta. The right ventricle of the heart was opened, and
the blood was allowed to escape. Cold (6–11°C) Na-, K-, and
Ca2-free solution containing 100 mM of trishydroxymethylamino-
methane and 220 mM of sucrose (pH adjusted at 7.4 by HCl, pO2 and
osmolality were 0 to 4 kPa and 300 to 330 mOsmol/g, respectively)
was used to wash out ions and blood from the vasculature and extra-
cellular space and to stop or at least reduce the activity of membrane
enzymes responsible for various membrane ion transports in the retina.
Two hundred milliliters of cold buffer washed out more than 90% of
the ions from the extracellular space.17 As described previously,18 a
short (30 seconds) washout period was optimal because a prolonged
cold perfusion may cause artifacts in ion distributions and destruction
of retinal tissue. Immediately after the washout period, the eye was
enucleated and rapidly opened, and the retina was progressively de-
tached from the retinal epithelium and finally dissociated by cutting
from the optic nerve.19 Retinal tissue was dried for 48 hours at 100°C
and then converted to ash at 550°C for 24 hours. The ash was dissolved
in 0.2 mL of 3 M nitric acid and diluted 10-fold with deionized water.
Tissue Na was measured at a wavelength of 330.3 nm, K at 404.4
nm, and Ca2 at 422.7 nm in an air acetylene flame by an atomic
absorption spectrophotometer (Perkin-Elmer, Wellesley, MA). The
washout perfusion method and the determination of tissue ion con-
tents have been described previously in different tissue.20 Because a
small amount of extracellular ions can contaminate the samples after
washing out the extracellular space,17 the values obtained in our
studies are termed retinal rather than intracellular ion contents.
Histology
In additional studies, for the fixation of retina, a cannula was intro-
duced through the heart into the aorta, and the right ventricle of the
heart was opened to allow blood to escape. For washout of blood
before fixation, a buffered solution of 0.9% NaCl (100 mL) was used. A
short (approximately 20 seconds) washout period was optimal, be-
cause prolonged perfusion before fixation may cause artifacts (e.g.,
edema formation) in the nervous tissue. One hundred milliliters of the
fixative solution (Bouin’s solutions) followed immediately without any
interruption of the NaCl perfusion. Then eyes were enucleated, rapidly
cut open, and divided in half by coronal section through the ora
serrata. The vitreous was removed, and the eye was immersed in
fixative solution (Bouin’s fluid). After fixation, the tissue was dehy-
drated in graded series of ethanol and embedded in paraffin. Sagittal
sections of 7 m were cut and stained with hematoxylin-eosin. Isch-
emia/reperfusion–induced cell swelling (edema formation) is well rec-
ognized and documented in the inner plexiform layer of the retina.21,22
The average of the retina’s thickness for each eye was measured in the
sagittal section at near the optic nerve, and expressed in micrometers
using a video-plan computer analyzer (Imstar, Paris, France) as we
3728 Szabo et al. IOVS, October 2004, Vol. 45, No. 10
previously described.11 Migration of neutrophils was observed after 90
minutes of ischemia followed by 24 hours of reperfusion.
Experimental Time Course
Before the onset of ischemia and reperfusion and the isolation of
retina, rats were treated orally with 5, 10, or 30 mg/kg per day of the
sour cherry seed flavonoids for 14 days. After 14 days’ pretreatment,
eyes were subjected to 90 minutes of ischemia followed by 24 hours of
reperfusion. At the end of reperfusion period, HO-1 protein expres-
sion, HO enzyme activity, HO-1–related CO production, and retinal
Na, K, and Ca2 contents were measured in untreated and drug
treated groups. Our study had two single objectives: the first was to
study the HO-1 related CO production in ischemic/reperfused retina.
The second objective of our work was to evaluate the degree to which
flavonoid-rich extract of sour cherry seeds may attenuate the changes
of retinal ion contents induced by ischemia/reperfusion.
The extract of sour cherry was produced by Papp Ltd. (Nyirtass,
Hungary). UV and gas chromatography–mass spectrometry analyses in
conjunction with HPLC showed that this novel sour cherry seed ex-
tract is 4% flavonoids, including quercetin, apigenin, rhamnetin, scutel-
lacein, and pinocembrin. This fraction was called the sour cherry
flavonoid–rich extract and used in our study. However, sour cherry
seeds were extracted using various steps and analyzed. Thus, sour
cherry seeds contain 37% of vegetable oil (triglycerides, oleic acids,
-tocopherol, tocotrienols, and tocopherol-like components) and 63%
of solid components of various molecular structures. The 4%, 4%, 4%,
3%, 2%, 1%, and 1% of the 63% solid components of sour cherry seed
extract are cianids, polyphenols, flavonoids, acids, pro- and anthocya-
nidines, stilbanes, and catechins, respectively.
The flavonoid-rich fraction of sour cherry seed extract was homog-
enized in 2 mL of 1% methylcellulose solution and then diluted with
0.9% of NaCl to 10 mL. Rats were orally treated daily with 10 mL/kg of
the solution (containing 5, 10, or 30 mg/kg of flavonoid-rich extract)
for 14 days, and no changes in the behavior and physical activities of
animals were observed during the treatment.
Statistics
Gaussian-distributed variables were expressed as the mean  the SEM
of CO production, HO enzyme activity, cations, and the thickness (in
micrometers) of the inner plexiform layer. Nonparametric distribution
(2 test) for neutrophil leukocyte migration was used and classified as
the presence or absence of neutrophil leukocytes.
RESULTS
Figure 1 shows the sagittal section of rat retina in nonischemic
control eye (Fig. 1A), in retina subjected to 90 minutes isch-
emia followed by 24 reperfusion without treatment (Fig. 1B),
in ischemic/reperfused (90 minutes/24 hours) retina treated
with 10 (Fig. 1C) and 30 (Fig. 1D) mg/kg sour cherry seed
extract for 14 days, respectively. In the drug-free ischemic/
reperfused retina (Fig. 1B), we observed many changes by
using hematoxylin–eosin staining in the inner nuclear layer.
There were more pyknotic, vacuolated spaces and degenera-
tive changes in ganglion cells. These changes were markedly
reduced in retinas subjected to ischemia/reperfusion and
treated with 10 (Fig. 1C) and 30 (Fig. 1D) mg/kg sour cherry
flavonoid–rich seed extract.
Figure 2 shows the thickness (in micrometers), as an indi-
cator of edema formation, of the retinal plexiform layer in eyes
subjected to 90 minutes of ischemia followed by 24 hours of
reperfusion in drug-free and drug-treated groups. Thus, a sig-
nificant reduction in the thickness of the inner plexiform layer
was observed in the ischemic/reperfused retina obtained from
rats treated with 10 and 30 mg/kg of sour cherry flavonoid–rich
extract, respectively (Fig. 2). The migration of neutrophils was
reduced by 75% in the groups treated with 30 mg/kg sour
cherry flavonoid–rich extract.
Figure 3 shows representative chromatograms of CO peaks
recorded (Fig. 3, chromatogram A) in the nonischemic retina;
and after 90 minutes of ischemia followed by 24 hours of
reperfusion (Fig. 3, chromatogram E) in the drug-free retina;
and in retina from rats treated with (Fig. 3, chromatogram B)
30 mg/kg, (Fig. 3 chromatogram C) 10 mg/kg, or (Fig. 3
chromatogram D) 5 mg/kg flavonoid-rich sour cherry seed
extract. Thus, the results clearly show that detectable endog-
enous CO production by GC can be observed in aerobically
perfused rat retina (Fig. 3, chromatogram A), and this CO peak
was substantially reduced in ischemic/reperfused drug-free ret-
ina (Fig. 3, chromatogram E). However, in the ischemic/reper-
FIGURE 1. Sagittal sections of rat retinas showing layer structures of
nonischemic control (A), retina subjected to 90 minutes of ischemia
followed by 24 hours of reperfusion (B), retina from rats treated with
10 mg/kg of sour cherry flavonoid–rich extract for 10 days and eyes
subjected to 90 minutes ischemia followed by 24 hours reperfusion
(C), and retina from rats treated with 30 mg/kg of sour cherry fla-
vonoid–rich extract obtained for 14 days, and eyes subjected to 90
minutes ischemia followed by 24 hours of reperfusion (D).
FIGURE 2. The effect of flavonoid-rich extract of sour cherry on the
extent of retinal edema indicating by the thickness (in micrometers) of
the inner plexiform layer in ischemic/reperfused eyes. Eyes were
subjected to 90 minutes of ischemia followed by 24 hours of reperfu-
sion. n  6 in each group, mean  SEM. Comparisons were made to
the drug-free thickness. *P  0.05.
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fused retina, a moderate increase in endogenous CO produc-
tion was measured in rats treated with 30, 10, or 5 /kg sour
cherry flavonoid–rich extract, respectively, returning toward
the concentration observed in the Figure 3, chromotogram A.
Insets in the Figure 3 (top) show the corresponding inte-
grated and calculated peak areas (n  5 in each group) of CO
curves expressed in arbitrary units in nonischemic control (Fig.
3A) retinas, in retinas obtained from rats treated with 30 mg/kg
(Fig. 3B; *P  0.05), 10 mg/kg (Fig. 3C; *P  0.05), or 5 mg/kg
(Fig. 3D) sour cherry flavonoid–rich extract, respectively, and
subjected to 90 minutes of ischemia followed by 24 hours of
reperfusion.
Insets in the Figure 3 show (bottom) the expression of HO-1
protein in nonischemic aerobic control retina (Fig. 3, lane A),
in ischemic/reperfused drug-free control retina (Fig. 3, lane E),
in ischemic/reperfused retina obtained from rats treated with
30 (Fig. 3, lane B), 10 (Fig. 3, lane C), or 5 (Fig. 3, lane D) mg/kg
flavonoid-rich extract. Thus, a downregulation in HO-1 protein
expression (approximately 10-fold) was observed in ischemic/
reperfused retina (Fig. 3, lane E) in comparison with the aer-
obically perfused nonischemic control retina (Fig. 3, lane A). In
rats treated with 5, 10, or 30 mg/kg sour cherry seed fla-
vonoid–rich extract and retinas were subjected to 90 minutes
ischemia followed by 24 hours of reperfusion, the expression
of HO-1 mRNA was increased approximately 1.5-, 5-fold, and
9-fold, respectively, in comparison with the ischemic/reper-
fused drug-free value.
HO enzyme activity (Fig. 4) was significantly reduced after
24 hours of reperfusion in drug-free ischemic/reperfused reti-
nas (Fig. 4, group 2) in comparison with the nonischemic
group (Fig. 4, group 1). However, a significant increase in HO
enzyme activity was observed in retinas (Fig. 4, group 3 and
group 4) treated with 10 or 30 mg/kg of flavonoid-rich sour
cherry seed extract, respectively, compared with the ischemic/
reperfused drug-free control group.
The effect of sour cherry flavonoid–rich seed extract was
tested in rat retina for its protective action against the
changes of retinal cation contents induced by 90 minutes
ischemia followed by 24 hours of reperfusion. Table 1
shows the basic levels of retinal Na, K, and Ca2 contents
(first column) in nonischemic retinas. After 90 minutes of
ischemia followed by 24 hours of reperfusion, there was a
significant increase in retinal Na and Ca2 contents from
nonischemic control levels of 51.7  2.8 and 2.1  0.1 g/g
dry weight to 94.2  3.2 and 4.8  0.2 g/g dry weight,
respectively. Tissue K was reduced from the nonischemic
control value of 303.4  5.1 to 229.6  4.2 g/g dry weight
(*P  0.05). These changes in ischemia/reperfusion-induced
retinal Na and Ca2 gains, and K loss were significantly
reduced in rats treated with 10 and 30 mg/kg sour cherry
flavonoid–rich extract (Table 1).
FIGURE 3. GC chromatograms for
the demonstration of endogenous
CO production in rat retina sub-
jected to 90 minutes of ischemia fol-
lowed by 24 hours of reperfusion.
Chromatogram A shows CO produc-
tion in intact retina, and chromato-
gram E represents tissue CO produc-
tion in retina subjected to 90 minutes
ischemia followed by 24 hours of
reperfusion. Rats were treated with
30 (B), 10 (C), or 5 (D) mg/kg fla-
vonoid-rich sour cherry extract for
14 days. Then eyes were subjected to
ischemia/reperfusion, and chromato-
grams were registered at the end of
reperfusion period. Insets show the
corresponding (A, B, C, D, and E)
levels of CO production (top inset, in
arbitrary units, mean  SEM of five
experiments in each group) and rep-
resentative Western blot analysis of
HO-1 protein expression (bottom).
*P  0.05 in comparison with the
ischemic/reperfused (E) drug-free
control values.
FIGURE 4. Effects of flavonoid-rich extract of sour cherry seeds on HO
enzyme activities in ischemic/reperfused rat retina. Group 1: nonisch-
emic control retina. Group 2: retinas were subjected to 90 minutes of
ischemia followed by 24 hours of reperfusion. Group 3: conditions of
ischemia/reperfusion protocol are the same as in the group 2, and rats
were treated with 10 mg/kg flavonoid-rich sour cherry extract for 14
days. Group 4: conditions of ischemia/reperfusion protocol are the
same as in the group 2, and rats were treated with 30 mg/kg flavonoid-
rich sour cherry extract for 14 days. n 6 in each group, mean SEM,
*P  0.05, comparisons were made to the ischemic/reperfused drug-
free control group (group 2).
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DISCUSSION
Occlusion of the central retinal artery is a true ophthalmic
emergency, when each minute elapsed increases the chance of
death of retina leading to vision loss. Although reperfusion is a
prerequisite for the survival and recovery of ischemic tissue, it
is emphasized that it is not without hazard, and reperfusion-
induced injury could occur. Mammalian cells and tissues re-
spond to injury by up- or downregulation of several stress-
related genes, the protein products of which, may participate
in the protection against cellular injury. Although the impor-
tance of HO-mediated endogenous CO production has been
identified recently as a protective mechanism in the regulation
of ischemia/reperfusion-induced damage in various or-
gans,23–26 the direct measurement of endogenous CO from
retinal tissue, to our knowledge, has not yet been performed.
Although the induction of HO-1 has recently been extensively
studied at the level of gene transcription,27,28 the physiological
function of this process is poorly understood in the context of
its role in the mechanism and regulation of reperfusion-in-
duced cellular injury. Therefore, in the present study, we have
endeavored to obtain additional circumstantial evidence for
the involvement of HO-1–related endogenous CO production
and its direct measurement in ischemic/reperfused rat retina.
Like nitric monoxide (NO), CO has been identified as an
endogenous cellular messenger, and studies suggest an impor-
tant role of CO in hemodynamic regulation.6 It has been shown
that endogenously produced CO acts as a signal molecule2 and
an activator of guanylate cyclase responsible for the generation
of cGMP in the vascular tissue.29 These findings suggest that
vessel wall-derived CO could serve as an endogenous regulator
of vascular tone and platelet activity. Thus, it has been sug-
gested that CO generated by heme catabolism may modulate
the activity of the metabotropic receptor suspected to be
neuroprotective during ischemic neuronal damage.30 CO may
also have the capacity to affect ischemic brain hemodynamics
positively, through its inhibitory role on platelet aggregation,
which may contribute to neuroprotection.31 In addition, the
capacity of CO to induce cGMP, with upregulation of the cell
survival signal bcl-2, together with inhibition of nuclear trans-
location of p53 protein, indicates an important role for the HO
system in modulating cell death/survival signals.30 It is also of
interest to note that CO binds and inactivates neuronal nitric
oxide synthetase leading to a reduced production of nitric
oxide by calcium influx into hypoxic neurons.32
In the present study involving measurement of retinal CO
production, we now provide direct evidence consistent with
the hypothesis that retinal CO production may play a key role
in the development of reperfusion-induced damage through
HO-1 protein induction in the retina. Using a flavonoid-rich
extract of sour cherry seed to stimulate HO-1 protein expres-
sion and endogenous CO production, we demonstrate that
increased endogenous CO production is associated with the
prevention of reperfusion-induced retinal damage. Mecha-
nisms by which elevated HO-1 expression leads to the increase
of endogenous CO production may involve the following: First,
flavonoids, which are naturally occurring compounds, have
been shown to modulate P-450–dependent metabolic activi-
ties in vitro and in vivo33,34 and to scavenge O2
- and OH-free
radicals. Flavonoids also act as antioxidants35,36 and have anti-
inflammatory activity.37 The specific action of flavonoids may
have been to increase the binding affinity of a substrate38 or to
improve the electron transfer efficacy between NADPH-cyto-
chrome P-450 reductase and the P-450 enzyme. The P-450
reductase, which transfers electrons from NADPH to P-450
during P-450–dependent catalysis, is capable of reducing ox-
ygen to yield superoxide anion, and the oxygenated interme-
diates of P-450 itself can decompose in a side reaction to
release superoxide anion.39 The second possible explanation
for increased induction of HO-1 and CO formation may involve
the elimination of reactive oxygen species and reducing their
direct interaction with cellular components including gene
transcription machinery. Therefore, with trapping of powerful
oxidizing radical species, the rate of decay in HO-1 protein
expression may decrease. Third, today, when so many ad-
vances are being made in molecular biology and cell physiol-
ogy, we tend to lose sight of the potential importance of basic
ions (e.g., Na, K, and Ca2) in both experimental and
clinical medicine. Our study emphasizes the importance of
Na, K, and Ca2 in the maintenance of ionic balance across
cell membranes, because various clinical conditions are fre-
quently complicated by vision loss that originates from the
ionic imbalance through edema formation and apoptotic or
necrotic cell death. Our findings provide a basis for inquiry but
do not dissociate the different routes and pathways involved in
the postischemic ion accumulation or loss in ischemic/reper-
fused retina. Thus, the connection between HO-1 gene and
protein expression-related CO formation could modify cellular
membrane ion transports, and an increase in HO-1 gene and
encoded protein expression could protect against changes in
cation concentrations caused by ischemia/reperfusion. Our
results show that Na and Ca2 accumulate in retina. An
increase in CO production by flavonoid-rich extract of sour
cherry through the HO-1 protein expression resulted in a
significant decrease in cellular Na and Ca2 contents leading
to a significant reduction of edema formation11 and mitochon-
drial calcium-overload–induced cell death, which is a key me-
diator or signal of necrosis and/or apoptosis.40,41
In summary, the results show that a downregulation in
HO-1 protein, HO-1–related CO production, and HO-1 enzyme
activity could play a crucial role in the development of reper-
fusion-induced retinal damage. Thus, it is reasonable to suggest
that interventions, which are able to increase endogenous CO
production through the HO-1 system, could prevent the devel-
opment of ischemia/reperfusion-induced injury including
changes in cation concentration and edema formation in the
retina. However, additional studies are needed to resolve the
links in the apparent cascade of the up- and downregulation of
ischemia/reperfusion-induced HO-1 protein expression, HO-1–
related CO generation, and enzyme activity in ischemic/reper-
fused retina.
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TABLE 1. Effects of Ischemia/Reperfusion and Sour Cherry
Flavonoid–rich Extract on Cellular Sodium, Potassium, and Calcium











Sodium 51.7  2.8 94.2  3.2 80.5  2.4 70.3  4.1
Potassium 303.4  5.1 229.6  4.2 248.7  3.3 263.8  5.9
Calcium 2.1  0.1 4.8  0.2 3.4  0.3 2.9  0.4
Data are expressed as mean micromoles per gram dry weight 
SEM. n  6 in each group. ISA, ischemia; RE, reperfusion.
* P 0.05 compared with the values of untreated (90 min ISA and
24 h RE) group.
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